Broad Institute

APRIL 25, 2024

Sabeti and her lab had also responded quickly to Ebola in 2014, working with hospitals and government officials in Sierra Leone to sequence viral genomes from patients and make the data available to local communities. Ozonoff is also an associate professor of pediatrics at Harvard Medical School and a scientist at Boston Children’s Hospital.

Virus 132

Virus Hospitals Disease Government 132

The Pharma Data

APRIL 27, 2023

RSV causes over 270,000 hospitalisations and approximately 20,000 in-hospital deaths in adults aged 60 years and older each year in Europe. This is the first time an RSV vaccine candidate for adults has gained a positive opinion, one of the final steps in the marketing authorisation procedure prior to approval by the European Commission.

Virus 40

Virus Vaccine Trials Clinical Trials 40

The Pharma Data

SEPTEMBER 28, 2020

The UK’s first hospital trust to record 1,000 Covid-19 deaths says the toll is the “terrible reality” of the virus. University Hospitals Birmingham, which has four hospitals and is the biggest trust in England, had reported 1,001 deaths since 14 March as of Sunday. Coronavirus pandemic.

Hospitals 52

Hospitals Virus 52

Broad Institute

JUNE 18, 2024

Simple test for flu could improve diagnosis and surveillance By Allessandra DiCorato June 18, 2024 Breadcrumb Home Simple test for flu could improve diagnosis and surveillance A low-cost CRISPR-based paper strip test distinguishes between influenza types and can be reprogrammed to recognize different viruses including the H5N1 bird flu virus.

Virus 143

Virus RNA Medical Schools Laboratories 143

Science Daily: Pharmacology News

DECEMBER 14, 2023

New research comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways.

Hospitals 104

Hospitals Virus Research 104

The Pharma Data

APRIL 7, 2022

announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV). NYSE: PFE) and ReViral Ltd.

Virus 52

Virus Vaccine Clinical Development Hospitals 52

The Pharma Data

APRIL 8, 2022

Using a Human Lung Chip that replicates the structures and functions of the lung air sac, or “alveolus,” the research team discovered that applying mechanical forces that mimic breathing motions suppresses influenza virus replication by activating protective innate immune responses. . During his Ph.D.

Virus 52

Virus Immune Response Disease Clinical Trials 52

Drug Discovery World

OCTOBER 17, 2023

In May 2015, the Department of Interventional Oncology of Renji Hospital in Shanghai collaborated with CARsgen Therapeutics to initiate the first clinical study with CAR T cell therapy targeting the GPC3 (Glypican-3) protein in advanced hepatocellular carcinoma.

Therapies 162

Therapies Hospitals Virus Treatment 162

SCIENMAG: Medicine & Health

JULY 13, 2023

As a result of the COVID-19 pandemic, respiratory syncytial virus (RSV) surges in young children occurred outside the usual November to March season, when immune-based prophylactic is available to protect children at high risk for severe illness.

Hospitals 70

Hospitals Virus 70

The Pharma Data

AUGUST 13, 2020

The number of people in hospital with Covid-19 fell in coronavirus hotspots in June and July, according to data released by NHS England. But scientists use hospital data to understand whether rising cases reflect more infections or more testing. More of these cases are among young people, who are less likely to become seriously sick.

Hospitals 52

Hospitals Virus Research 52

The Pharma Data

AUGUST 24, 2020

They say genome sequencing shows the two strains of the virus are “clearly different”, making it the world’s first proven case of reinfection. Those infected develop an immune response as their bodies fight off the virus which helps to protect them against it returning.

Virus 52

Virus Immune Response Hospitals Vaccine 52

The Pharma Data

SEPTEMBER 18, 2020

Cases of the virus and hospital admissions for Covid-19 are thought to be doubling every seven to eight days in the UK. And the scientist behind the Covid Symptom Study app said it appeared to be “the start of a second wave” The developments come as new England-wide restrictions are being discussed. At least 13.5

Virus 52

Virus Government Hospitals 52

Drug Discovery World

JUNE 6, 2024

The global Phase III clinical trial is being led by University College London Hospitals NHS Foundation Trust in the UK and will include around 1,100 people. Moderna recently secured FDA approval for the first mRNA vaccine to treat something other than Covid-19 – it’s respiratory syncytial virus (RSV) vaccine mRESVIA (mRNA-1345).

Vaccine 147

Vaccine Clinical Trials FDA Approval Research Laboratories 147

Drug Discovery World

AUGUST 23, 2023

The US Food and Drug Administration (FDA) has approved the first vaccine for pregnant individuals to prevent respiratory syncytial virus (RSV) in infants.

FDA Approval 130

FDA Approval Vaccine FDA Virus 130

The Pharma Data

SEPTEMBER 4, 2020

The main test used to diagnose coronavirus is so sensitive it could be picking up fragments of dead virus from old infections, scientists say. He believes the detection of traces of old virus could partly explain why the number of cases is rising while hospital admissions remain stable. Image copyright. Getty Images.

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

AUGUST 7, 2020

Individuals in hospitals and care homes are not included in the ONS survey, which has been estimating cases in private households since May. This means there are stricter rules on socialising for people living in these areas and for businesses, in order to control the spread of the virus. Source link.

Virus 52

Virus Hospitals 52

Drug Discovery World

AUGUST 24, 2022

It will also assess the time taken until throat and lesion swabs test negative for monkeypox virus and the proportion of patients who require hospitalisation due to complications from the disease. . Tecovirimat prevents the Monkeypox virus from leaving infected cells, helping stop its spread within the body.

Research 246

Research Clinical Trials Virus Trials 246

The Pharma Data

DECEMBER 9, 2020

9, 2020 — In a sign that the COVID-19 pandemic is entering its most dire stage yet, new federal data show that more than a third of Americans now live in areas where hospitals are critically short of intensive care beds. WEDNESDAY, Dec. When you don’t have that capacity, that means people will die.”

Hospitals 52

Hospitals Doctors Virus Government 52

SCIENMAG: Medicine & Health

JANUARY 16, 2024

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

Virus 93

Virus Hospitals 93

The Pharma Data

JUNE 7, 2023

RSV is a common, contagious respiratory virus that leads to over 270,000 hospitalisations and approximately 20,000 in-hospital deaths each year in adults aged 60 years and over in Europe. The authorisation is based on GSK’s landmark positive pivotal AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial data.

Virus 40

Virus Vaccine Disease Trials 40

Drug Discovery World

OCTOBER 13, 2023

The project involves teams from the University Hospitals of Derby and Burton NHS Foundation Trust and the University of Exeter, in collaboration with Gilead Sciences. A UK-based study will investigate whether a common anti-viral medication could double up as a treatment for long Covid.

Medical Schools 147

Medical Schools Hospitals Virus Treatment 147

The Pharma Data

NOVEMBER 4, 2020

Not only cases are spiking: the number of people hospitalized with COVID-19 has reached record highs in a growing number of states. Missouri, Oklahoma, Iowa, Indiana, Nebraska, North Dakota and New Mexico all reported record high hospitalizations this week, the Associated Press reported. Meanwhile, Brazil passed 5.5

Hospitals 52

Hospitals Vaccine Government Virus 52

Broad Institute

FEBRUARY 8, 2024

By Allessandra DiCorato February 8, 2024 Credit: NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland Scanning electron image of the Lassa virus budding off a cell. Other scientists had discovered that this gene was critical for the Lassa virus to enter cells.

Research 82

Research Virus Hospitals FDA Approval 82

The Pharma Data

JANUARY 29, 2021

SARS-CoV-2 Seroconversion Tied to Out-of-Hospital Sudden Deaths. from Lenox Hill Hospital in New York City, and colleagues examined the association between OHSD and SARS-CoV-2 epidemiologic burden during the first wave of the COVID-19 pandemic across neighborhoods of NYC. Professional. FRIDAY, Jan. FRIDAY, Jan. Coleman, R.N.,

Hospitals 52

Hospitals Virus Research 52

The Pharma Data

DECEMBER 1, 2020

1, 2020 — Yet another grim record for COVID-19 hospitalizations was set on Monday, as more than 96,000 patients battled severe cases of the virus in hospital wards across America. But the number of hospitalizations have risen by more than 12 percent over the past week, the newspaper noted. TUESDAY, Dec.

Hospitals 52

Hospitals Vaccine Virus Government 52

Drug Discovery World

JUNE 23, 2023

The Food and Drug Administration (FDA) has granted accelerated approval to Elevidys (delandistrogene moxeparvovec-rokl), an adeno-associated virus (AAV) based gene therapy for the treatment of DMD. Sarepta Therapeutics’ Elevidys has become the first gene therapy for Duchenne muscular dystrophy (DMD) to gain marketing authorisation in the US.

FDA Approval 243

FDA Approval Therapies FDA Protein Expression 243

The Pharma Data

APRIL 25, 2021

Nirsevimab demonstrate d protect ion against respiratory syncytial virus disease in healthy infants in Phase 3 trial. Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization in all infants. RSV is the most common cause of LRTI and the leading cause of hospitalizations in all infants. 1 – 5.

Virus 40

Virus Trials Disease Hospitals 40

The Pharma Data

MARCH 23, 2022

“When the COVID-19 pandemic started, our multidisciplinary research teams switched our investigations of other viruses and bacteria to focus on a potential treatment for what was then a challenging new virus for us,” says Children’s Center microbiologist Lori Jones-Brando, Ph.D., alone each year.

Virus 52

Virus Immune Response Research Treatment 52

Drug Discovery World

JULY 7, 2023

They found that patients with more frequent antibiotic exposure in the past three years were at higher odds of experiencing severe Covid-19 outcomes, including hospital admission and 30-day mortality. Plus, using a range of antibiotics was more likely to be associated with Covid-19 hospital admission.

Hospitals 130

Hospitals Virus Research Treatment 130

The Pharma Data

SEPTEMBER 10, 2020

The disruption to hospitals in England during the pandemic has meant the number of patients facing long waits for routine operations has soared. But there are some encouraging signs, with treatments happening in hospitals on the increase. Image copyright. Getty Images. Image copyright. Getty Images.

Hospitals 52

Hospitals Treatment Virus 52

The Pharma Data

MAY 16, 2022

million symptomatic cases of the virus, as well as 690,000 hospitalizations and more than 110,000 deaths. The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.

Vaccine 52

Vaccine Hospitals Virus Production 52

Drug Discovery World

FEBRUARY 1, 2024

The importance of speed and efficiency crystalises when you see a virus like SARS-CoV-2 spreading across the globe, sending thousands of people to the hospital every week. Traditionally, therapeutic antibody discovery is labour and resource intensive. Accordingly, these innovations are increasingly adopted for biologics development.

Virus 162

Virus Production Engineering Hospitals 162

The Pharma Data

SEPTEMBER 30, 2020

. ‘Compelling case’ But he said the pandemic had “massively impacted normal NHS services” And this situation could have been improved with clearer communication to patients and better infection control measures in hospitals. “And there may need to be difficult decisions made about what services to prioritise.

Virus 52

Virus Government Nurses Hospitals 52

The Pharma Data

DECEMBER 9, 2020

9, 2020 – In a sign that the coronavirus pandemic is entering its most dire stage yet, new federal data shows that more than a third of Americans now live in areas where hospitals are critically short of intensive care beds. The new hospital data shows that some areas — like Amarillo, Texas, Coral Gables, Fla., WEDNESDAY, Dec.

Hospitals 52

Hospitals Vaccine Government Doctors 52

The Pharma Data

MARCH 3, 2022

If approved by the FDA, this maternal immunization has the potential to be the first vaccine candidate to help protect infants in their vulnerable first months of life from disease caused by this highly-contagious virus. Burden of RSV RSV is a contagious virus and a common cause of respiratory illness. Pfizer Inc.

Virus 52

Virus Vaccine Clinical Trials FDA 52

Drug Discovery World

AUGUST 31, 2022

The study authors suggest that antigen levels could help determine those patients most likely to benefit from therapies directed at fighting the virus. . Analysis of Covid patient blood samples. High blood antigen levels also correlated with some known risk factors for worse illness, such as being male.

Hospitals 130

Hospitals Trials Virus International 130

Drug Discovery World

SEPTEMBER 13, 2023

The results The study shows that over 80% of the patients hospitalised in a psychiatry department near Paris during the first wave of the Covid-19 pandemic had been exposed to SARS-CoV-2, which was 1.6 times more than the control group.

Protein Expression 130

Protein Expression Clinical Trials Hospitals Trials 130